scholarly journals Microfoam sclerotherapy of superficial venous malformations of the upper limbs

2021 ◽  
Vol 18 (2) ◽  
pp. 163-168
Author(s):  
V. Yu. Bogachev ◽  
B. V. Boldin ◽  
A. Yu. Samenkov
Keyword(s):  
Arteriovenous Malformations ◽  
Lower Limbs ◽  
Bleeding Complications ◽  
Upper Limbs ◽  
Venous Malformations ◽  
Foam Sclerotherapy ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Invasive Techniques

Venous malformations are the most common type of angiodysplasia, which cause both physiological and emotional discomfort to patients. Arteriovenous malformations occur most often in the upper and lower limbs at the ratio of 20.9% and 46.4%, respectively. On top of that, 70% of cases of superficial arteriovenous malformations are found in women. In this article, the authors present a clinical example of the effectiveness of microfoam sclerotherapy and show a long-term outcome in a patient with superficial venous malformations of her hands, which are accompanied with such symptoms as as pain and bleeding. As a sclerosing agent, a 1–3% sodium tetradecyl sulphate solution was used, followed by compression using class 2 garments (RAL standard) such as an arm sleeve and gloves. The interval between procedures was 4 to 6 weeks. After several sessions, the superficial venous malformations of the upper limb decreased in the size and volume, and the patient presented less complaints. A 5-year follow-up showed no growth of malformations and re-bleeding complications. Microfoam sclerotherapy of superficial venous malformations in the upper limbs (hands) has good long-term outcomes and allows patients to avoid traumatic surgery. Given this comparability of the surgical and minimally invasive techniques, the use of the latter option, in particular, the foam sclerotherapy technique, makes economic and financial sense.

Linear Accelerator Stereotactic Radiosurgery in the Management of Intracranial Arteriovenous Malformations: Long-Term Outcome

2014 ◽  
Vol 37 (5) ◽  
pp. 342-349 ◽  
Author(s):  
Yu-Chi Wang ◽  
Yin-Cheng Huang ◽  
Hsien-Chih Chen ◽  
Kuo-Cheng Wei ◽  
Cheng-Nen Chang ◽  
...  
Keyword(s):  
Stereotactic Radiosurgery ◽  
Linear Accelerator ◽  
Arteriovenous Malformations ◽  
Intracranial Arteriovenous Malformations ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals ENDOVENOUS LAZER COAGULATION: LONG-TERM RESULT - CRITERION OF TRUTH

2018 ◽  
Vol 3 (4) ◽  
pp. 27-30
Author(s):  
A G Shalashov ◽  
A V Kazantsev
Keyword(s):  
Varicose Veins ◽  
Intraoperative Complications ◽  
Lower Limbs ◽  
Long Term Results ◽  
Laser Coagulation ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Long Term Result ◽  
Varicose Disease

Objectives - to study the long-term results of endovenous laser coagulation in patients with varicose veins of the lower extremities. Material and methods. The study included 241 patients with varicose disease of the lower limbs veins, who underwent surgical treatment using the method of endovenous laser coagulation. Results. The technical success of the operation was achieved in all cases, which was confirmed by color duplex scanning. There were no intraoperative complications. Long-term outcome was studied in 174 (72.2%) patients in the period up to 5 years. During the follow-up period the GSV occlusion signs were detected in 168 (96.4%) patients, partial recanalization of the GSV was registered in 6 (3.5%) patients.

Catheter-based treatment of ilio-femoral deep vein thrombosis - an update on current evidence

VASA ◽  
2013 ◽  
Vol 42 (3) ◽  
pp. 161-167 ◽  
Author(s):  
Jennifer Fahrni ◽  
Rolf P. Engelberger ◽  
Nils Kucher ◽  
Torsten Willenberg ◽  
Iris Baumgartner
Keyword(s):  
Deep Vein Thrombosis ◽  
High Rate ◽  
Current Evidence ◽  
Bleeding Complications ◽  
Postthrombotic Syndrome ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Vein Thrombosis ◽  
Deep Vein

Ilio-femoral deep vein thrombosis (DVT) has a high rate of long-term morbidity in the form of the postthrombotic syndrome (PTS). Therefore, management of acute thrombosis should not only focus on the prevention of acute complications such as propagation or embolisation of the initial clot but also on preventing PTS and recurrent thrombosis. Contemporary catheter-based treatments of deep vein thrombosis have proven to be safe and effective in selected patients. Current guidelines recommend medical therapy with anticoagulation alone for all but the most severe, limb-threatening thrombosis. They additionally allow for consideration of catheter-based treatment in patients with acute DVT and low risk of bleeding complications to prevent PTS. Recent studies favoring interventional therapy have not been included in these guidelines. Data on long-term outcome is expected to be published soon, clarifying and very likely strengthening the role of catheter-based treatments in the management of acute ilio-femoral DVT.

Long-term outcome after surgical excision of parenchymal arteriovenous malformations in patients over 60 years of age

1997 ◽  
Vol 47 (3) ◽  
pp. 258-263 ◽  
Author(s):  
Giuseppe Lanzino ◽  
Allan H. Fergus ◽  
Mary E. Jensen ◽  
Gail L. Kongable ◽  
Neal F. Kassell
Keyword(s):  
Arteriovenous Malformations ◽  
Surgical Excision ◽  
Term Outcome ◽  
Long Term Outcome

Long-Term Outcome of Embolotherapy and Surgery for High-Flow Extremity Arteriovenous Malformations

2000 ◽  
Vol 11 (10) ◽  
pp. 1285-1295 ◽  
Author(s):  
Robert I. White ◽  
Jeffrey Pollak ◽  
John Persing ◽  
Katharine J. Henderson ◽  
J. Grant Thomson ◽  
...  
Keyword(s):  
Arteriovenous Malformations ◽  
High Flow ◽  
Term Outcome ◽  
Long Term Outcome

Characteristics and Long-Term Outcome of 127 Children With Cerebral Arteriovenous Malformations

Neurosurgery ◽  
2018 ◽  
Vol 84 (1) ◽  
pp. 151-159 ◽  
Author(s):  
Elias Oulasvirta ◽  
Päivi Koroknay-Pál ◽  
Ahmad Hafez ◽  
Ahmed Abou Elseoud ◽  
Hanna Lehto ◽  
...  
Keyword(s):  
Arteriovenous Malformations ◽  
Cerebral Arteriovenous Malformations ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-Term Outcome of 106 Consecutive Pediatric Ruptured Brain Arteriovenous Malformations After Combined Treatment

Stroke ◽  
2014 ◽  
Vol 45 (6) ◽  
pp. 1664-1671 ◽  
Author(s):  
Thomas Blauwblomme ◽  
Marie Bourgeois ◽  
Philippe Meyer ◽  
Stéphanie Puget ◽  
Federico Di Rocco ◽  
...  
Keyword(s):  
Arteriovenous Malformations ◽  
Combined Treatment ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Brain Arteriovenous Malformations

Long-term outcome and anaesthetic management for non-cardiac surgery after Fontan palliation: a single-centre retrospective analysis

2014 ◽  
Vol 25 (6) ◽  
pp. 1148-1154 ◽  
Author(s):  
Thomas Palumbo ◽  
Thierry Sluysmans ◽  
Jean E. Rubay ◽  
Alain J. Poncelet ◽  
Mona Momeni
Keyword(s):  
Cardiac Surgery ◽  
Surgical Techniques ◽  
Bleeding Complications ◽  
Term Outcome ◽  
Term Survival ◽  
Long Term Outcome ◽  
Extracardiac Conduit ◽  
Lateral Tunnel ◽  
Significant Difference

AbstractObjectives: The improved management of Fontan patients has resulted in good outcome. As such, these patients may necessitate care for non-cardiac surgery. We sought to determine the long-term outcome of our Fontan series palliated with the most recent surgical techniques. Our second objective was to report the incidence and the perioperative course after non-cardiac procedures. We reviewed the records of all patients with either a lateral tunnel or an extracardiac conduit Fontan between 1996 and 2008. Follow-up was recorded until June, 2013, including records regarding non-cardiac interventions. Results: Overall, 58 patients were included. Of them, one patient underwent a takedown of his Fontan, and five patients died in the immediate postoperative course. The cumulative survival of the remaining 52 patients was 81%. There was no significant difference in survival between right and left ventricle morphologies (p=0.56), nor between both types of Fontan (p=0.9). Chronic arrhythmias (25%), fatigue/dyspnoea (40%), thrombotic complications (19%), and embolic events (10%) were among the most recurrent comorbidities. In total, 45 non-cardiac interventions were performed on 26 patients, with three bleeding complications and one death. Conclusions: This study shows excellent long-term survival after both lateral tunnel and extracardiac conduit Fontan. The incidence of cardiovascular morbidity remains high, however. We also report a high number of non-cardiac interventions. Thorough understanding of the Fontan physiology is mandatory when non-cardiac anaesthesiologists are in charge of these patients.

scholarly journals Long-Term Outcome with New Generation Prostheses in Patients Undergoing Transcatheter Aortic Valve Replacement

2021 ◽  
Vol 10 (14) ◽  
pp. 3102
Author(s):  
Alexander R. Tamm ◽  
Martin Geyer ◽  
Felix Kreidel ◽  
Lea Dausmann ◽  
Caroline Jablonski ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Bleeding Complications ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Transcatheter Aortic Valve ◽  
New Generation

The aim of this study was to compare patients with transcatheter aortic valve replacement (TAVR) receiving new generation prostheses SAPIEN 3 (S3, Edwards Lifesc.) and Evolut R (ER, Medtronic Inc.) in terms of periprocedural and long-term outcome. Our retrospective, single-center analysis included 359 consecutive patients with severe aortic stenosis who underwent TAVR with S3 or ER from 2014–2016 (mean age 82 ± 7 years, 47% male, mean EuroSCORE II 8.0 ± 8%, mean follow-up 3.8 years). Device Success was equal (S3 93.0% vs. ER 92.4%, p = 0.812). We report a 30-day mortality of 2.8% in the S3 group, and 2.1% in the ER group (p = 0.674). There was no difference in stroke, conversion to open surgery, vascular and bleeding complications or myocardial infarction. While prosthesis mean gradients were higher with S3 (12.0 mmHg vs. 8.2 mmHg, p < 0.001), there was a trend to less paravalvular regurgitation (PVR moderate or severe: 1% vs. 3.6%, p = 0.088). All-cause mortality up to 5 years did not show a difference (mean survival S3 3.5 ± 0.24 years, ER 3.3 ± 0.29 years, p = 0.895). Independent predictors of long-term mortality were impaired LVEF, chronic kidney injury, peripheral artery disease, malignant tumor and periprocedural stroke. New generation TAVR valves offer an excellent implant and outcome success rate. Long-term survival was independent of prostheses choice and mainly attributed to comorbidities and complications.

Sign in / Sign up

Export Citation Format

Share Document